The Charnoly Body: A Novel Biomarker of Mitochondrial Bioenergetics

New
Illustrated
2019
$218.92

This book highlights Charnoly body (CB) prevention/inhibition, charnolophagy induction, and charnolosome stabilization, as targets for safe and effective treatment of chronic intractable diseases (CIDs) including: Fetal Alcohol Syndrome, Zika Virus Disease, Alzheimer's Disease, Cardiovascular Diseases, Major Depression, and Multi-Drug-Resistant Malignancies. Emerging glycomics, genomics, and epigenomics are described to further elucidate diversified charnolopathies. In addition, ROS scavenging antioxidant loaded nanoparticles are proposed to enhance drug delivery and charnolophagy for intracellular detoxification. These concepts are original, interesting, thought-provoking, and motivate young scientists, doctors, and other healthcare professionals to discover novel charnolopharmacotherapeutics for personalized theranostics of CIDs to enjoy better quality of life.

Synopsis

This book highlights Charnoly body (CB) prevention/inhibition, charnolophagy induction, and charnolosome stabilization, as targets for safe and effective treatment of chronic intractable diseases (CIDs) including: Fetal Alcohol Syndrome, Zika Virus Disease, Alzheimer's Disease, Cardiovascular Diseases, Major Depression, and Multi-Drug-Resistant Malignancies. Emerging glycomics, genomics, and epigenomics are described to further elucidate diversified charnolopathies. In addition, ROS scavenging antioxidant loaded nanoparticles are proposed to enhance drug delivery and charnolophagy for intracellular detoxification. These concepts are original, interesting, thought-provoking, and motivate young scientists, doctors, and other healthcare professionals to discover novel charnolopharmacotherapeutics for personalized theranostics of CIDs to enjoy better quality of life.

$218.92

Quantity

20+ in stock

More Information

Format: Illustrated
Pages: 466
Edition: 1
Publisher: CRC Press
Published: 22 Feb 2019
ISBN 10: 1138557161
ISBN 13: 9781138557161

Author Bio

Dr Sushil Sharma is a Professor and Course Director of Pharmacology at the Saint James School of Medicine in Saint Vincent & Grenadines. He received Ph.D. in Neuropharmacology from A.I.IM.S, New Delhi; Radiopharmaceutical Trainings from BARC, Bombay, GE, Siemens, Agilent Technologies, & Cardinal Health in the U.S. He has organized and chaired several world conferences, has been awarded 5 gold medals, a certificate of honor at I.T Nano-2014 Conference, Boston. (Original Discoveries: Electromicroinjector; Charnoly Body in Purkinje Neurons, IL-10 Receptors on Cortical Neurons, & MTs-Gene-Manipulated Mice), and authored 235 publications.